Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)
Open Access
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 7 (1) , 31
- https://doi.org/10.1186/1475-2840-7-31
Abstract
Current guidelines from the European Society of Cardiology (ESC) define low thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol (LDL-C) to guide treatment. Although being mainly a prevention tool, its thresholds are difficult to meet in clinical practice, especially primary care. In a nationwide study with 1,511 primary care physicians and 35,869 patients we determined the prevalence of dyslipidemia, its recognition, treatment, and control rates. Diagnosis of dyslipidemia was based on TC and LDL-C. Basic descriptive statistics and prevalence rate ratios, as well as 95% confidence intervals were calculated. Dyslipidemia was highly frequent in primary care (76% overall). 48.6% of male and 39.9% of female patients with dyslipidemia was diagnosed by the physicians. Life style intervention did however control dyslipidemia in about 10% of patients only. A higher proportion (34.1% of male and 26.7% female) was controlled when receiving pharmacotherapy. The chance to be diagnosed and subsequently controlled using pharmacotherapy was higher in male (PRR 1.15; 95%CI 1.12–1.17), in patients with concomitant cardiovascular risk factors, in patients with hypertension (PRR 1.20; 95%CI 1.05–1.37) and cardiovascular disease (PRR 1.46; 95%CI 1.29–1.64), previous myocardial infarction (PRR 1.32; 95%CI 1.19–1.47), and if patients knew to be hypertensive (PRR 1.18; 95%CI 1.04–1.34) or knew about their prior myocardial infarction (PRR 1.17; 95%CI 1.23–1.53). Thresholds of the ESC seem to be difficult to meet. A simple call for more aggressive treatment or higher patient compliance is apparently not enough to enhance the proportion of controlled patients. A shift towards a multifactorial treatment considering lifestyle interventions and pharmacotherapy to reduce weight and lipids may be the only way in a population where just to be normal is certainly not ideal.Keywords
This publication has 26 references indexed in Scilit:
- Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary careCurrent Medical Research and Opinion, 2008
- The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician–patient communicationCurrent Medical Research and Opinion, 2008
- Diabetes and lipid screening among patients in primary care: A cohort studyBMC Health Services Research, 2008
- Prevalence and treatment of dyslipidemia in canadian primary care: A retrospective cohort analysisClinical Therapeutics, 2007
- Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in GermanyAtherosclerosis, 2007
- Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trialsBMJ, 2006
- Primary prevention of cardiovascular diseaseDeutsche Medizinische Wochenschrift (1946), 2004
- High prevalence and poor control of hypertension in primary careJournal Of Hypertension, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998